Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine – New England Journal of Medicine Commentaries: Peer-reviewed report on Moderna COVID-19 vaccine publishes – NIH News Releases AND Peer-reviewed data show high protection for leading COVID vaccines – CIDRAP AND The Moderna Vaccine’s Antibodies May Not Last As Long As We Hoped – Forbes   Commentary […]

The post Moderna COVID-19 vaccine phase III trial results published; it is 94.1% efficacious in preventing symptomatic COVID-19 appeared first on Links Medicus.